Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University-Reference-Cited by-同舟云学术

Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University

Published:2006-06 Issue:6 Volume:13 Page:834-837
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

HINATA NOBUYUKI,SHIRAKAWA TOSHIRO,TERAO SHUJI,GODA KAZUMASA,TANAKA KAZUSHI,YAMADA YUJI,HARA ISAO,KAMIDONO SADAO,FUJISAWA MASATO,GOTOH AKINOBU

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2006.01418.x/fullpdf

Reference10 articles.

1. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis;Matsubara;Cancer Res.,2001

2. Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models;Ko;Cancer Res.,1996

3. Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model;Cheon;Cancer Gene Ther.,1997

4. Exploiting stromal-epithelial interaction for model development and new strategies of gene therapy for prostate cancer and osteosarcoma metastases;Gardner;Gene Ther. Mol. Biol.,1998

5. In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy;Shirakawa;Cancer Gene Ther.,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics;Asian Journal of Urology;2019-01

2. Polymeric oncolytic adenovirus for cancer gene therapy;Journal of Controlled Release;2015-12

3. Personalized medicine-based strategy for prostate cancer;Personalized Medicine Universe;2014-07

4. Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma;Human Gene Therapy Clinical Development;2013-09

5. Vitamin D3-Inducible Mesenchymal Stem Cell-Based Delivery of Conditionally Replicating Adenoviruses Effectively Targets Renal Cell Carcinoma and Inhibits Tumor Growth;Molecular Pharmaceutics;2012-04-16